Advertising: In London, A Trial Over An Anonymous Blog Testimony has offered new insights into the hands-on style of the chief executive of the WPP Group, and the strong feelings it has sometimes produced.... Read Full Article Tempus: Goodbye Moto In a fast-changing and fiercely competitive market like mobile handsets, sitting still is not an option. But, as last night’s catastrophic trading update from Motorola shows, it has done j... Read Full Article Cash Calls Pointing Way To Bottom Of The Market Having spent most of this decade returning vast sums of cash to shareholders, the stock market suddenly wants it back.... Read Full Article Property Prices Poised For A Giddying Climb Every now and again you come across a statistic that signals a turning point.... Read Full Article The Hunt For The Invisible Man The detectives at Sherlock Investigations get strange requests all the time. There was the mysterious disappearance of Captain Jack, an iguana that was stolen out of the window of a ground-floor... Read Full Article |
Glaxo NewsGlaxo Says Compound in Wine May Fight AgingThe British drug maker said it would acquire a biotechnology company that is pursuing the notion that a compound found in red wine might retard aging.Read Full Article Glaxo Says Wine May Fight AgingThe British drug maker said it would acquire a biotechnology company that is pursuing the notion that a compound found in red wine might retard aging.Read Full Article Glaxo Smith Kline boss to retire with £2.5m handshakeJean Pierre Garnier, the head of Glaxo Smith Kline, will bow out of the pharmaceutical giant on a sour note after being granted options that will see him benefit from a potential £2.5 million bonus long after he has left the company.Read Full Article Tempus: DSG ... Silverjet ... GlaxoDSG: Short circuitRead Full Article F.D.A. Reviewing H.I.V. Drugs for Heart RiskThe Food and Drug Administration said that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.Read Full Article External News for: glaxoReport: Glaxo pulling 170000 H1N1 doses in Canada - Local Tech WireTimes OnlineReport: Glaxo pulling 170000 H1N1 doses in CanadaLocal Tech Wireglaxosmithkline has asked several provinces to set aside the 170000 doses from the questionable batch, the private TV network said. ...SPECIAL COVERAGE: H1N1 Influenza NewsNurse.comGlaxo recalls 170000 doses of H1N1 vaccine in CanadaTriangle Business JournalSwine flu vaccine: US wouldn't have a shortage if it embraced enhanced versionDaily Finance (blog)Reuters -Center for Research on Globalization -TheChronicleHerald.caall 4,213 news articles »Report: Glaxo pulling 170000 H1N1 doses in Canada - Local Tech WireTimes OnlineReport: Glaxo pulling 170000 H1N1 doses in CanadaLocal Tech Wireglaxosmithkline has asked several provinces to set aside the 170000 doses from the questionable batch, the private TV network said. ...SPECIAL COVERAGE: H1N1 Influenza NewsNurse.comGlaxo recalls 170000 doses of H1N1 vaccine in CanadaTriangle Business JournalSwine flu vaccine: US wouldn't have a shortage if it embraced enhanced versionDaily Finance (blog)Reuters -Center for Research on Globalization -TheChronicleHerald.caall 4,213 news articles »Glaxo buys rights to smoking vaccine - Chicago Daily HeraldTelegraph.co.ukGlaxo buys rights to smoking vaccineChicago Daily HeraldGlaxoSmithKline Plc. may pay more than $500 million for rights to an experimental drug that could help tobacco smokers permanently kick their addiction to ...Nabi, Glaxo agree nicotine vaccine licensing dealMarketWatchGlaxoSmithKline, Nabi Biopharmactuticals In Licensing PactWall Street JournalGlaxo in deal for smoking vaccinePhiladelphia InquirerWashington Post -AHN -Hindustan Timesall 199 news articles »Report: Glaxo pulling 170000 H1N1 doses in Canada - Local Tech WireTimes OnlineReport: Glaxo pulling 170000 H1N1 doses in CanadaLocal Tech Wireglaxosmithkline has asked several provinces to set aside the 170000 doses from the questionable batch, the private TV network said. ...SPECIAL COVERAGE: H1N1 Influenza NewsNurse.comGlaxo recalls 170000 doses of H1N1 vaccine in CanadaTriangle Business JournalSwine flu vaccine: US wouldn't have a shortage if it embraced enhanced versionDaily Finance (blog)Reuters -Center for Research on Globalization -TheChronicleHerald.caall 4,213 news articles »Glaxo buys rights to smoking vaccine - Chicago Daily HeraldTelegraph.co.ukGlaxo buys rights to smoking vaccineChicago Daily HeraldGlaxoSmithKline Plc. may pay more than $500 million for rights to an experimental drug that could help tobacco smokers permanently kick their addiction to ...Nabi, Glaxo agree nicotine vaccine licensing dealMarketWatchGlaxoSmithKline, Nabi Biopharmactuticals In Licensing PactWall Street JournalGlaxo in deal for smoking vaccinePhiladelphia InquirerWashington Post -AHN -Hindustan Timesall 199 news articles »Glaxo sees Benlysta as "very major" opportunity - ReutersVisit BulgariaGlaxo sees Benlysta as "very major" opportunityReutersGlaxo and partner Human Genome Sciences Inc (HGSI.O: Quote, Profile, Research, Stock Buzz) reported results from two clinical trials showing that patients ...Reuters Summit-Glaxo CEO sees no big slide in marginsAlibaba News ChannelGlaxo Reports Higher RevenuesZacks.comSide Effects Unknown for New Swine Flu Vaccine from GlaxoSmithKline - Package ...Examiner.comJoplin Globe -Portfolio.com -TopNews Arab Emiratesall 38 news articles » |
i8news.com |
